XNY Medical’s Post

Endometriosis often goes undiagnosed or misdiagnosed due in part to the various forms the condition can take, including symptoms that mimic those of other medical conditions. It can take years to receive a diagnosis, which typically occurs through an invasive surgery called a laparoscopy. Our research involves developing an early detection method that is more accessible for patients and less invasive. Learn more: https://lnkd.in/g6TwPjWD

A new collaboration to be added to my research contributions 😁😁 A very important research in to study the benefit of associated operation with Bariatric Surgery operations such as cholecystectomy, hilatal hernia repair, unmibilical hernia repair. https://lnkd.in/eCsRgvCC

November 2024 marks a milestone as the first overseas surgery using the Japan-made hinotori™ Surgical Robot System was successfully performed at Singapore General Hospital. This breakthrough highlights the growing global demand for minimally invasive, robot-assisted procedures that prioritize patient comfort and surgical precision. With regulatory approvals in Singapore and Malaysia, Sysmex is advancing its mission to revolutionize surgery worldwide. From urology to thoracic procedures, the hinotori™ continues to redefine standards of care, ensuring safer, more efficient outcomes for patients. Read the full article: https://lnkd.in/eXw8tNZM #MinimallyInvasiveSurgery #HealthcareTransformation #MedicalInnovation #ehealthmarket #eindustrynews Sysmex Corporation MedEdge MEA

💉Prophylactic (perioperative) #antibiotics are rarely needed, however, when we decide to use them we should use them right. Historically beta-lactams were administered 30–60 minutes before the first incision in dogs, then every 90 minutes until the end of surgery. Dr. Ludovic Pelligand from RVC wanted more evidence and conducted a study on the pharmacokinetics/pharmacodynamics of each most commonly used beta-lactams for surgical prophylaxis which helps us choose a more accurate time of dosing for each antibiotic based on expected contamination. For more details check and download the poster and hang it in your surgical theatres 👉🏼bit.ly/3ZvjOAm

Venus Medtech (SEHK: 2500) achieved a significant milestone with the successful completion of the first tricuspid valve replacement surgery in the Asia-Pacific region using its innovative Cardiovalve system. This marks Cardiovalve's inaugural entry into the Asia-Pacific region following its successful clinical applications across Europe, North America, and other regions, symbolizing a notable advancement in Venus Medtech's global influence. The surgery was a collaborative effort between Professor Kent So's team at Prince of Wales Hospital, The Chinese University of Hong Kong, and a multidisciplinary team. Immediate postoperative outcomes were favorable, and the patient is currently recuperating well, with plans for discharge in the near future. This milestone also represents the first humanitarian patient treated with Cardiovalve in the Asia-Pacific region, underscoring the unique clinical advantages offered by this product. #QMPortfolio #QMHealthcare #VenusMedtech #Cardiovalve #TricuspidValveReplacement #MedicalInnovation 

⚕️ Follow us for the Session Series Part 3 of the Scientific Program @ The National Symposium of Bariatric & Metabolic Surgery! ⚕️ Session III – GERD, hiatal hernia and bariatric surgery! Gastroesophageal reflux disease (GERD) is frequently associated with obesity. Up to half of the obese patients who are going to have bariatric surgery have GERD and hiatal hernia. Postoperative control of GERD is done through the appropriate choice of the type of bariatric surgery and through surgical techniques performed simultaneously, representing an extremely important weapon in preventing the occurrence of evolutive complications with negative potential on the quality of life. As a result, the session "GERD, Hiatal Hernia and bariatric surgery" include current and future topics about hiatal hernia repair during laparoscopic sleeve gastrectomy, postoperative intrathoracic gastric migration and the use of LRYGBP in patients with GERD. Meet the Speakers: https://shorturl.at/dLaHO www.arcecongres.ro ⚕️Stay tuned for the next sessions!

12/11/24: SamanTree Medical Highlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at the 2024 SABCS "These outstanding results underscore the potential of the Histolog Scanner to enhance oncologic surgical outcomes significantly," said Olivier Delporte, CEO of SamanTree Medical SA Medical. "By enabling real-time, high-resolution tissue microstructure assessments during BCS, our technology addresses a critical unmet need, reducing reoperation rates and improving patient outcomes. Read why at https://lnkd.in/e3e7nV4K

#Collaboration 🤝 | RDS is thrilled to be part of the groundbreaking eCAP collaborative project! Discover the projects's promotional video today! The eCAP project is developing a revolutionary medical device that combines a smart capsule with an advanced e-health platform to improve diagnostics and empower patients in managing gastrointestinal (GI) diseases— an increasingly prevalent issue worldwide. 🏥💡 This innovative solution will feature a modular, implantable capsule with multi-sensing capabilities, allowing for GI physiology monitoring via minimally invasive endoscopy. By leveraging cloud computing, smartphone connectivity, and AI-driven data analysis, eCAP will enable clinicians to personalize tests and provide patients with more accurate and actionable results. 📱💻 We are excited to be part of this effort, which will: ▪️ Improve diagnostics and disease management for GI disorders such as gastroesophageal reflux disease (GERD) 🫶 ▪️ Make advanced GI diagnostics more accessible and more affordable 🌐 ▪️ Empower patients and train healthcare practitioners worldwide through specialized education programs 📚👩⚕️ eCAP is more than just a device—it’s a vision to shift GI diagnostics to a scalable, patient-centered e-health solution, positioning Europe as a leader in connected medical devices and remote patient monitoring. Stay tuned as we help drive this medical innovation forward! 💙 Learn more about the eCAP project: www.ehealth-cap.eu #HealthcareInnovation #eCAPProject #DigitalHealth #GIDiagnostics #ConnectedDevices #RemotePatientMonitoring #AIinHealthcare #HorizonEurope Institut de Chirurgie guidée par l'Image (IHU Strasbourg) Tyndall National Institute Sentron, a Millar® Company EnteraSense Limited RDS Olymed Gastro Zentrum Betthera AMIRES

Life-Saving Intervention: Managing a Mesenteric Hematoma during Surgery A recent case at Sterling Hospitals highlights the importance of prompt and effective management of surgical complications. Under the expert care of Dr. Hitesh Chavda, our team successfully managed a mesenteric hematoma that occurred during a total radical colectomy, utilizing angioembolization to stabilize the patient and prevent further complications. Read the full case study to learn more about our team's expertise and approach to managing complex surgical cases: https://lnkd.in/g5kFcFbC #SterlingHospitals #MesentericHematoma #TotalRadicalColectomy #Angioembolization #SurgicalIntervention #PatientCare #MedicalExcellence

Great to see the first experience in Latin America of the Combat PRS+ recirculation system with CO2 agitation getting some attention at the 4th Latin American Congress on Peritoneal Neoplasms in Frutillar, Chile last week.   “The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is the treatment of choice for selected patients with peritoneal carcinomatosis.   “Although CRS techniques are standardized, HIPEC presents variability in chemotherapy agents, doses, temperature, duration, and administration methods, which limits its optimization.   “In recent years, a new technique has been introduced, which is safe and efficient for performing HIPEC using the Peritoneal Recirculation System with CO2 agitation (COMBAT PRS+A®), opening new possibilities in the management of peritoneal carcinomatosis.”   More tomorrow!   #medicalinnovation #LatinAmerica #peritonealcancer #HIPEC #CombatPRS+ #CombatMedical